Barclays’s Rennova Health, Inc. RNVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-111
Closed 7351
2017
Q3
$0 Hold
111
﹤0.01% 7245
2017
Q2
$1K Hold
111
﹤0.01% 6588
2017
Q1
$3K Buy
+111
New +$3.66K ﹤0.01% 6433

Barclays's RNVA Position: Q4 2017 in Review

Barclays sold out of Rennova Health, Inc. (RNVA) in Q4 2017, closing a stake of 111 shares.

Barclays first reported a position in RNVA in Q1 2017 and held it in 3 quarters. The position peaked at $3K in Q1 2017. 1 fund tracked by Wall St. Rank holds RNVA as of Q4 2017.

  • Barclays reported no remaining Rennova Health, Inc. position as of Q4 2017 after selling out during the quarter.
  • Barclays sold 111 Rennova Health, Inc. shares in Q4 2017.
  • Barclays first reported a position in Rennova Health, Inc. in Q1 2017 and held it in 3 quarters.
  • Barclays's Rennova Health, Inc. position peaked at $3K in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Rennova Health, Inc. as of Q4 2017.

Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.